Applied Photophysics adds Paul Walker to its Board as Non-Executive Director

– UK, Surrey – Applied Photophysics, a leading provider of systems for biophysical characterization of biomolecules, today announced it has appointed Paul Walker as Non-Executive Director. The appointment completes the formation of the Company’s Board of Directors, which will provide a key strategic resource for directing future investment opportunities and building awareness of the Company and its product portfolio.

Paul held technical and management roles in the steel industry before establishing his own management consultancy. In 1993 he joined Malvern Instruments, a biotech instruments supplier, where he has been Managing Director for the past 20 years. Paul was awarded an MBE for services to Industry in 2012 and was Chairman of the Hereford and Worcestershire Chamber of Commerce for five years. He has been a Non-Executive Director of the Malvern Hills Science Park since 1999 and is a Fellow of the University of Worcester. Paul is a Chartered Engineer with B. Tech and M. Phil degrees in Materials Science from Bradford University. He joins a highly-experienced team on the Applied Photophysics Board.

Commenting on the appointment, Louise Madden, CEO and Executive Director at Applied Photophysics, said: “The appointment of Paul to our Board of Directors underlines our strategic focus on strengthening and expanding our position in the biophysical characterization market. With their many years of experience and proven success in running biotech tools companies and generating investor interest, we will draw on the Board’s extensive network to raise awareness of our new generation, state-of-the-art Chirascan systems and identify synergistic opportunities.”

About Applied Photophysics

Applied Photophysics is a leading provider of systems and accessories for the biophysical characterization of biomolecules. The Company’s SX-range of stopped-flow spectrometers, used to monitor changes in absorbance and fluorescence during fast biological reactions, is acknowledged globally as the gold standard for kinetic studies. Headquartered in the UK, with offices in Boston and Shanghai, Applied Photophysics has been established for more than 40 years. In 2005, the Company introduced the first Chirascan™ system, using the phenomenon of circular dichroism (CD) to characterize changes in protein structure and stability. Since then, the Company has continued to incorporate its in-depth knowledge and understanding of CD into a range of Chirascan products that are used in cutting-edge research and to support the development of innovator drugs and biosimilars in the biopharmaceutical industry. Compared to conventional CD instruments, the new generation of Chirascan systems ensures that every scientist gets the most from every CD analysis.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>